JARDY MET 12.5MG 1000MG TAB 14s

Jardy Met 12.5mg/1000mg Tablet 14s – Dual Action Therapy for Type 2 Diabetes

Overview: Jardy Met Tablet combines Empagliflozin (12.5mg) and Metformin (1000mg), offering a powerful, dual-action oral therapy for managing type 2 diabetes mellitus. It works by enhancing insulin sensitivity, reducing glucose absorption, and promoting urinary glucose excretion.

Key Benefits:

• Combines SGLT2 inhibitor (Empagliflozin) with Metformin for synergistic blood glucose control

• Helps reduce HbA1c, fasting, and postprandial glucose levels

• Promotes weight reduction and blood pressure control

• Low risk of hypoglycemia when used alone

• Supports cardiovascular and renal protection in diabetics

Indications:

• For adults with type 2 diabetes mellitus inadequately controlled by Metformin or other antidiabetic agents

• Especially beneficial for patients with comorbid cardiovascular or renal risk

Dosage:

• One tablet usually taken once or twice daily with meals

• Dosage individualized based on patient response and tolerability

Precautions:

• Not suitable for type 1 diabetes or diabetic ketoacidosis

• Monitor kidney function and stay hydrated

• Possible side effects: urinary tract infections, thirst, increased urination, mild GI upset

Packaging:

• Pack of 14 tablets, usually in blister form

• For prescription use only

SEO Meta Description (under 160 characters): Jardy Met 12.5mg/1000mg Tablet combines Empagliflozin & Metformin to manage type 2 diabetes, support weight loss, and protect